Decarboxylated osteocalcin, a possible drug for type 2 diabetes, triggers glucose uptake in MG63 cells

BACKGROUND: Uncarboxylated osteocalcin (GluOC) has been reported to improve glucose metabolism, prevent type 2 diabetes, and decrease the severity of obesity in mice with type 2 diabetes. GluOC can increase glucose uptake in a variety of cells. Glucose metabolism is the main source of energy for ost...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Shi, Chang, Xiao-Cen, Wen, Jing, Yang, Jing, Ao, Na, Zhang, Ke-Ying, Suo, Lin-Na, Du, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311485/
https://www.ncbi.nlm.nih.gov/pubmed/34326958
http://dx.doi.org/10.4239/wjd.v12.i7.1102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311485/
https://www.ncbi.nlm.nih.gov/pubmed/34326958
http://dx.doi.org/10.4239/wjd.v12.i7.1102

Ejemplares similares